These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 11760645)
1. [Clinical symptoms, diagnosis and treatment of focal dystonias]. Klivényi P; Vécsei L Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645 [TBL] [Abstract][Full Text] [Related]
2. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin]. Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208 [TBL] [Abstract][Full Text] [Related]
3. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin]. Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035 [TBL] [Abstract][Full Text] [Related]
4. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm]. Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore. Tan AK Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719 [TBL] [Abstract][Full Text] [Related]
7. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Kenney C; Jankovic J J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461 [TBL] [Abstract][Full Text] [Related]
10. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin]. Saraux H J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019 [TBL] [Abstract][Full Text] [Related]
12. [Neurologic indications of botulin in adults]. Sotaniemi K Duodecim; 2011; 127(22):2409-14. PubMed ID: 22238918 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
14. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm. Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684 [TBL] [Abstract][Full Text] [Related]
15. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm]. Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919 [TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin in neurology]. Vidailhet M Rev Med Interne; 2005 Jul; 26(7):531-3. PubMed ID: 15975692 [No Abstract] [Full Text] [Related]
17. [Hemifacial spasm]. Krystkowiak P Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481 [TBL] [Abstract][Full Text] [Related]
18. Facial dystonia, essential blepharospasm and hemifacial spasm. Holds JB; White GL; Thiese SM; Anderson RL Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553 [TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin A: experience in the treatment of 115 patients]. Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404 [TBL] [Abstract][Full Text] [Related]